+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Evaluation of a rapid automated assay for analysis of von Willebrand ristocetin cofactor activity



Evaluation of a rapid automated assay for analysis of von Willebrand ristocetin cofactor activity



Clinical and Applied Thrombosis/Hemostasis 12(1): 61-67



A commercially available turbidometric assay has been evaluated for the measurement of von Willebrand factor ristocetin cofactor activity (VWF:RCo). The assay is simple, rapid, and can be cost-effectively performed on automated coagulation analyzers. This study's aim is to illustrate the performance of the automated VWF:RCo assay and its capacity to identify patients with von Willebrand disease (VWD). By direct comparison with a conventional VWF:RCo assay, performed on an aggregometer, the concordance between the two assays was 96%. With minor modifications, the automated assay showed a detection level of 0.03 kIU/L with linearity to 2.00 kIU/L. The imprecision of the automated assay was reduced compared to the conventional assay procedure with CV of 6.8% at the 1.00 kIU/L level and 8.6% at the 0.30 kIU/L level. The automated VWF:RCo assay was also suitable as a screening test to detect VWD in patients investigated for the cause of an increased bleeding tendency. In this situation the automated VWF:RCo assay was tested simultaneously with an automated immunoassay for von Willebrand antigen. Receiver operating curves for the diagnosis of VWD showed a greater area under the curve for the automated VWF:RCo assay compared to the immunoassay, 0.98 vs. 0.94, although the difference did not reach significance. In conclusion, the modified automated VWF:RCo assay shows better precision, lower detection limit, is faster to perform with a lower cost per test compared to the conventional aggregometer based VWF:RCo activity method and is an alternative to an antigen immunoassay as a screening test for VWD.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 048993905

Download citation: RISBibTeXText

PMID: 16444436

DOI: 10.1177/107602960601200110


Related references

A rapid, automated VWF ristocetin cofactor activity assay improves reliability in the diagnosis of Von Willebrand disease. Thrombosis Research 127(4): 341-344, 2011

Comparison of a new automated von Willebrand factor activity assay with an aggregation von Willebrand ristocetin cofactor activity assay for the diagnosis of von Willebrand disease. Blood Coagulation and Fibrinolysis 17(5): 353-358, 2006

Improved performance characteristics of the von Willebrand factor ristocetin cofactor activity assay using a novel automated assay protocol. Journal of Thrombosis and Haemostasis 8(10): 2216-2223, 2010

Evaluation of an automated von Willebrand Ristocetin cofactor assay on the Behring Coagulation Timer. Blood 90(10 Suppl. 1 Part 2): 91B, 1997

Validation of improved performance characteristics for the automated von Willebrand factor ristocetin cofactor activity assay. Journal of Thrombosis and Haemostasis 8(12): 2842-2844, 2010

Evaluation of Two Automated Methods for Measurement of the Ristocetin Cofactor Activity of von Willebrand Factor. Thrombosis and Haemostasis 88(7): 56-59, 2002

Evaluation of two automated methods for measurement of the ristocetin cofactor activity of von Willebrand factor. Thrombosis and Haemostasis 88(1): 56-59, 2002

A rapid assay for ristocetin cofactor activity using an automated coagulometer (ACL 9000). Blood Coagulation & Fibrinolysis 15(6): 505-511, 2004

A two-centre comparative evaluation of new automated assays for von Willebrand factor ristocetin cofactor activity and antigen. Haemophilia 20(1): 147-153, 2014

Use of the collagen-binding assay for von Willebrand factor in the analysis of type 2M von Willebrand disease: A comparison with the ristocetin cofactor assay. British Journal of Haematology 116(1): 187-192, 2002

Von Willebrand factor ristocetin cofactor (VWF:RCo) assay: implementation on an automated coagulometer (ACL). Journal of Thrombosis and Haemostasis 3(12): 2684-2688, 2005

Evaluation of an automated platelet-based assay of ristocetin cofactor activity. Haemophilia 17(2): 252-256, 2011

Rapid and accurate method for the von Willebrand factor ristocetin cofactor assay using 96-well microtiter plates. Journal of Thrombosis and Haemostasis 7(7): 1226-1228, 2009

Optimization of the automated, CS-2000i™ method for measuring low levels of von Willebrand factor ristocetin cofactor activity (VWF:RCo). International Journal of Hematology 101(2): 126-132, 2015

Comparison of von Willebrand factor (VWF) activity levels determined by HemosIL AcuStar assay and HemosIL LIA assay with ristocetin cofactor assay by aggregometry. Haemophilia 22(3): E200-E207, 2016